Oxford University Hospitals Nhs Foundation Trust investment portfolio

Arcturis Data curates precision, regulatory‑grade real‑world health data—enriched electronic patient records that include clinical notes, laboratory, genetic, imaging and biomarker information—to support drug discovery, development and launch. Its services are aimed at pharmaceutical, biotech and research organisations that need detailed patient‑level data for therapeutic research across disease areas.

Beacon Therapeutics Holdings Limited develops and advances gene‑therapy treatments for retinal diseases that cause blindness, including its lead clinical asset laru‑zova (AGTC‑501) for X‑linked retinitis pigmentosa. The company’s focus is on delivering ophthalmic gene‑therapy products for patients with rare and prevalent retinal disorders.